Abstract
Although structurally related to other steroid thyroid hormone nuclear receptors, Nur77, Nurr1 and NOR-1 represent a distinct subfamily of nuclear receptors, the Nur77 receptor subfamily. In addition to very strong structural homologies among these three nuclear receptors, all can be rapidly induced as immediate early genes. Furthermore, they have similar DNA binding and transactivation properties, and can function in the absence of a not yet known ligand(s). The present review addresses the properties of the Nur77 receptor subfamily, including gene structure, promotor elements, regulation of expression, DNA binding and transactivation properties, and potential physiological and developmental roles. The functions of all three receptors in negative selection of T-cells, the regulation of the hypothalamus-pituitary-adrenal axis and the potential functional redundancy are discussed. Also reviewed is the role of Nurr1 in the differentiation and function of midbrain dopaminergic neurons, as demonstra ted by the ablation of Nurr1 function in mice, and the potential implications for Nurr1 in Parkinsons disease and or schizophrenia. Although similar in many structural and functional aspects, subtle differences in certain properties, regulation and expression patterns of the different receptors may result in different physiological roles of these proteins, while similarities may account for a redundancy of function. Much has been described about the regulation of these proteins, however, future research will need to focus on the identification of potential ligands and the target genes that are regulated by this unique class of transcription factors.
Keywords: Nur77 Receptor, Hormone Nuclear Receptors, Nurr1, Parkinsons disease, Schizophrenia, protein, Promoter Structure, In Vitro DNA Binding, Transactivation
Current Genomics
Title: Structure and Function of the Nur77 Receptor Subfamily, a Unique Class of Hormone Nuclear Receptors
Volume: 1 Issue: 2
Author(s): J. B. Eells, J. Witta, J. B. Otridge, E. Zuffova and V. M. Nikodem
Affiliation:
Keywords: Nur77 Receptor, Hormone Nuclear Receptors, Nurr1, Parkinsons disease, Schizophrenia, protein, Promoter Structure, In Vitro DNA Binding, Transactivation
Abstract: Although structurally related to other steroid thyroid hormone nuclear receptors, Nur77, Nurr1 and NOR-1 represent a distinct subfamily of nuclear receptors, the Nur77 receptor subfamily. In addition to very strong structural homologies among these three nuclear receptors, all can be rapidly induced as immediate early genes. Furthermore, they have similar DNA binding and transactivation properties, and can function in the absence of a not yet known ligand(s). The present review addresses the properties of the Nur77 receptor subfamily, including gene structure, promotor elements, regulation of expression, DNA binding and transactivation properties, and potential physiological and developmental roles. The functions of all three receptors in negative selection of T-cells, the regulation of the hypothalamus-pituitary-adrenal axis and the potential functional redundancy are discussed. Also reviewed is the role of Nurr1 in the differentiation and function of midbrain dopaminergic neurons, as demonstra ted by the ablation of Nurr1 function in mice, and the potential implications for Nurr1 in Parkinsons disease and or schizophrenia. Although similar in many structural and functional aspects, subtle differences in certain properties, regulation and expression patterns of the different receptors may result in different physiological roles of these proteins, while similarities may account for a redundancy of function. Much has been described about the regulation of these proteins, however, future research will need to focus on the identification of potential ligands and the target genes that are regulated by this unique class of transcription factors.
Export Options
About this article
Cite this article as:
Eells B. J., Witta J., Otridge B. J., Zuffova E. and Nikodem M. V., Structure and Function of the Nur77 Receptor Subfamily, a Unique Class of Hormone Nuclear Receptors, Current Genomics 2000; 1 (2) . https://dx.doi.org/10.2174/1389202003351580
DOI https://dx.doi.org/10.2174/1389202003351580 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design Effect of Polyherbal Drug Majun Falasfa on the Transgenic Drosophila Model of Parkinson’s Disease
Current Traditional Medicine Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study
Current Drug Targets HLA-G - From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases
Current Immunology Reviews (Discontinued) Network Medicine and High Throughput Screening
Current Drug Discovery Technologies Role of Neurotrophic Factors in Parkinson's Disease
Current Pharmaceutical Design Intraventricular Human Immunoglobulin Distributes Extensively but Fails to Modify Amyloid in a Mouse Model of Amyloid Deposition
Current Alzheimer Research Involvement of the Endogenous Opioid System in Cannabinoid Responses
Current Medicinal Chemistry - Central Nervous System Agents HSV Amplicons: Neuro Applications
Current Gene Therapy Organotypic Cultures as Tools for Testing Neuroactive Drugs – Link Between In-Vitro and In-Vivo Experiments
Current Medicinal Chemistry Hypothalamic and Neuroendocrine Changes in Huntingtons Disease
Current Drug Targets Effect of Temperature and pH on the Secondary Structure and Denaturation Process of Jumbo Squid Hepatopancreas Cathepsin D.
Protein & Peptide Letters Budesonide: Teaching an Old Dog New Tricks for Inflammatory Bowel Disease Treatment
Current Medicinal Chemistry Association of SORL1 Gene Variants with Hippocampal and Cerebral Atrophy and Alzheimer's Disease
Current Alzheimer Research Natural Products as Sources of New Lead Compounds for the Treatment of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Conference Report: 182nd AAAS Annual Meeting, Washington DC, February 11-15, 2016
CNS & Neurological Disorders - Drug Targets Stem Cell Behavior at Hypothermia: A Review Article
Current Stem Cell Research & Therapy Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents
Anti-Cancer Agents in Medicinal Chemistry Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?
Current Medicinal Chemistry